Continuum Health Ventures
VC Fund
Toronto, Canada
Continuum Health Ventures is a early-stage Digital Health, Healthtech and Longevity Venture Capital fund.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Continuum Health Ventures invests in
Stages Continuum Health Ventures invests in
Countries Continuum Health Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Daniel Kraft
|
|||
Ricky Mehra
|
|||
Investment Focus
Industry
- Artificial Intelligence 5 (56%)
- Health Care 4 (44%)
- Biotechnology 3 (33%)
- Software 2 (22%)
- Machine Learning 2 (22%)
Stage
- Seed 4 (44%)
- Series A 4 (44%)
Country
- United States 5 (56%)
- Canada 2 (22%)
- United Kingdom 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Daniel Kraft
General Partner; General Partner
|
General Partner; General Partner | Total investments: 0 | Find email | |
|
Ricky Mehra
Founder, General Partner
|
Founder, General Partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ViewsML
|
ViewsML leverages artificial intelligence to enhance virtual diagnostics and precision medicine. The company focuses on transforming spatial biology and translational research by utilizing virtual biomarkers. Their technology aims to improve patient outcomes by providing deeper insights into healthcare diagnostics. ViewsML is involved in developingimmunohistochemistry technology to streamline the diagnostic process and support research objectives efficiently. | $4.9M / Seed / Apr 20, 2026 | |
Ampa Health
|
Ampa Health is a health technology business developing scalable brain stimulation technologies to treat depression, anxiety, and addiction. | $8.5M / Seed / Oct 22, 2025 | |
CardiaTec Biosciences
|
CardiaTec is a TechBio business that uses computational tools to unravel the biology underlying cardiovascular illness. CardiaTec uses massive and high-dimensional human omics data to better understand complicated disease biology and identify novel and differentiated therapies. | $6.5M / Seed / Sep 10, 2024 | |
Immunis
|
Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline. | $25M / Series A / Jul 01, 2024 | |
BeeKeeperAI
|
BeeKeeperAI is a zero trust collaboration platform protecting both algorithm IP and regulated data. | $12.1M / Series A / Jun 27, 2023 | |
Biotia
|
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid and precise infectious disease discovery. Their software and laboratory technology enable clinicians and researchers to guide patient treatment and improve health outcomes. | $8M / Series A / Aug 23, 2022 | |
|
Immunis
|
Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline. | $10M / Series A / Aug 03, 2022 | |
Enara Health
|
Enara Health is a fitness app that offers personalized weight loss programs with professionals such as doctors, dietitians, and assistants. Its algorithm program backs medical care providers to use key insights such as genes, blook work, medical, and weight history to find the right nutrition, exercise, and medication plan. | $6M / Seed / Apr 04, 2022 | |
Sanctuary Cognitive Systems Corporation
|
Sanctuary AI is an artificial general intelligence company founded in January 2018, and is based in Vancouver, B.C. Sanctuary's mission is to build synthetic humans – “synths” – that are indistinguishable from us physically, cognitively and emotionally. The company is structured to explore both cutting edge technology and the ethical issuesthat arise from creating human-like machines. | $59.7M / Series A / Mar 02, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Continuum Health Ventures invest in?
Continuum Health Ventures invests primarily in Artificial Intelligence, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Continuum Health Ventures?
Public channels for Continuum Health Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Continuum Health Ventures?
The team at Continuum Health Ventures includes Daniel Kraft (General Partner; General Partner) and Ricky Mehra (Founder, General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
